Samira Majjaj

2.0k total citations
24 papers, 902 citations indexed

About

Samira Majjaj is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Samira Majjaj has authored 24 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Samira Majjaj's work include Breast Cancer Treatment Studies (7 papers), Cancer Genomics and Diagnostics (6 papers) and Molecular Biology Techniques and Applications (4 papers). Samira Majjaj is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer Genomics and Diagnostics (6 papers) and Molecular Biology Techniques and Applications (4 papers). Samira Majjaj collaborates with scholars based in Belgium, United States and Italy. Samira Majjaj's co-authors include Christos Sotiriou, Martine Piccart, Benjamin Haibe‐Kains, Christine Desmedt, Denis Larsimont, Françoise Rothé, Michail Ignatiadis, Sherene Loi, Virginie Durbecq and Olivier Marinx and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Samira Majjaj

22 papers receiving 884 citations

Peers

Countries citing papers authored by Samira Majjaj

Since Specialization

Citations

This map shows the geographic impact of Samira Majjaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samira Majjaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samira Majjaj more than expected).

Fields of papers citing papers by Samira Majjaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samira Majjaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samira Majjaj. The network helps show where Samira Majjaj may publish in the future.

Co-authorship network of co-authors of Samira Majjaj

This figure shows the co-authorship network connecting the top 25 collaborators of Samira Majjaj. A scholar is included among the top collaborators of Samira Majjaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samira Majjaj. Samira Majjaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial 2024 ·Clinical Cancer Research ·Mattia Rediti, Danai Fimereli, (unknown), Zéna Wimana, David Venet, Patrick Flamen, Thomas Guiot, Elisabeth G.E. de Vries, Carolina P. Schröder, C. Willemien Menke‐van der Houven van Oordt, Marion Maetens, Samira Majjaj, Denis Larsimont, Françoise Rothé, Christos Sotiriou, Géraldine Gebhart	3
2	Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial 2024 ·Nature Communications ·Mattia Rediti, David Venet, (unknown), Marion Maetens, Delphine Vincent, Samira Majjaj, Sarra El-Abed, Serena Di Cosimo, Takayuki Ueno, Miguel Izquierdo, Martine Piccart, Lajos Pusztai, Sherene Loi, Roberto Salgado, G. Viale, Françoise Rothé, Christos Sotiriou	3
3	The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab 2024 ·ESMO Open ·Laurence Buisseret, Yacine Barèche, David Venet, (unknown), Andrea Gombos, Patrick Emonts, Samira Majjaj, Ghizlane Rouas, (unknown), Véronique Debien, Elisa Agostinetto, Soizic Garaud, Karen Willard‐Gallo, Denis Larsimont, John Stagg, (unknown), Christos Sotiriou	4
4	Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22–00 2023 ·Clinical Cancer Research ·(unknown), Mattia Rediti, David Venet, Samira Majjaj, Roswitha Kammler, Elisabetta Munzone, Lorenzo Gianni, Beat Thürlimann, (unknown), Marco Colleoni, Sherene Loi, Giuseppe Viale, Meredith M. Regan, Laurence Buisseret, Françoise Rothé, Christos Sotiriou	7
5	Abstract PD9-07: Role of immunosuppressive JNK pathway in the tumor microenvironment among Triple Negative Breast Cancer subtypes in IBCSG Trial 22-00 2023 ·Cancer Research ·(unknown), Takashi Semba, Mattia Rediti, Daniel J. McGrail, Xuemei Xie, Xiaoping Wang, (unknown), David Venet, Samira Majjaj, Roswitha Kammler, Marco Colleoni, Sherene Loi, Giuseppe Viale, Meredith M. Regan, Françoise Rothé, Christos Sotiriou, Naoto T. Ueno	1
6	Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer 2020 ·Clinical Cancer Research ·François Richard, Samira Majjaj, David Venet, Françoise Rothé, (unknown), Bram Boeckx, Caterina Marchiò, Florian Clatot, François Bertucci, Odette Mariani, Christine Galant, Gert Van den Eynden, Roberto Salgado, Elia Biganzoli, Diether Lambrechts, Anne Vincent‐Salomon, Giancarlo Pruneri, Denis Larsimont, Christos Sotiriou, Christine Desmedt	19
7	Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome 2020 ·EBioMedicine ·David Venet, Danai Fimereli, Françoise Rothé, Bram Boeckx, Marion Maetens, Samira Majjaj, Ghizlane Rouas, Maria Capra, Giuseppina Bonizzi, (unknown), Christine Galant, Martine Piccart, Giancarlo Pruneri, Denis Larsimont, Diether Lambrechts, Christine Desmedt, Christos Sotiriou	25
8	Abstract P3-07-04: Molecular characterization of mucinous breast cancers 2019 ·Cancer Research ·Christine Desmedt, Isabelle Veys, Bastien Nguyen, Sophia Leduc, Yacine Barèche, Samira Majjaj, Bram Boeckx, Diether Lambrechts, Christos Sotiriou	1
9	Genomic, Transcriptomic, Epigenetic, and Immune Profiling of Mucinous Breast Cancer 2019 ·JNCI Journal of the National Cancer Institute ·Bastien Nguyen, Isabelle Veys, Sophia Leduc, Yacine Barèche, Samira Majjaj, David N. Brown, Bram Boeckx, Diether Lambrechts, Christos Sotiriou, Denis Larsimont, Christine Desmedt	20
10	Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations 2018 ·npj Breast Cancer ·Bastien Nguyen, David Venet, Hatem A. Azim, David N. Brown, Christine Desmedt, Matteo Lambertini, Samira Majjaj, Giancarlo Pruneri, Fedro A. Peccatori, Martine Piccart, Françoise Rothé, Christos Sotiriou	22
11	Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays 2018 ·PLoS ONE ·Vinu José, Debora Fumagalli, Françoise Rothé, Samira Majjaj, Sherene Loi, Stefan Michiels, Christos Sotiriou	3
12	Biology of breast cancer during pregnancy using genomic profiling 2014 ·Endocrine Related Cancer ·Hamdy A. Azim, (unknown), Fedro A. Peccatori, Christine Desmedt, Sherene Loi, Diether Lambrechts, Patrizia Dell’Orto, Samira Majjaj, Vinu José, Nicole Rotmensz, Michail Ignatiadis, Giancarlo Pruneri, M. Piccart, (unknown), (unknown)	47
13	Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology 2014 ·BMC Genomics ·Debora Fumagalli, Alexis Blanchet-Cohen, David N. Brown, Christine Desmedt, David Gacquer, Stefan Michiels, Françoise Rothé, Samira Majjaj, Roberto Salgado, Denis Larsimont, Michail Ignatiadis, Marion Maetens, Martine Piccart, Vincent Detours, Christos Sotiriou, Benjamin Haibe‐Kains	42
14	Abstract P1-07-08: Effect of sample preservation method and transportation duration on tumor gene expression profiling in breast cancer. 2012 ·Cancer Research ·Debora Fumagalli, Vinu José, Roberto Salgado, Samira Majjaj, Sandeep K. Singhal, Delphine Vincent, Marion Maetens, Denis Larsimont, (unknown), Phuong Dinh, M. Piccart, Stefan Michiels, Christos Sotiriou, Sherene Loi	1
15	Abstract P3-04-10: Comparison between RNA-Seq and Affymetrix gene expression data 2012 ·Cancer Research ·Debora Fumagalli, Benjamin Haibe‐Kains, Stefan Michiels, (unknown), David Gacquer, Samira Majjaj, Rocío Salgado, Denis Larsimont, (unknown), M. Piccart, Christos Sotiriou, Christine Desmedt	1
16	Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer 2011 ·PLoS ONE ·Françoise Rothé, Michail Ignatiadis, Carole Chaboteaux, Benjamin Haibe‐Kains, Naı̈ma Kheddoumi, Samira Majjaj, Bassam Badran, Hussein Fayyad‐Kazan, Christine Desmedt, Adrian L. Harris, Martine Piccart, Christos Sotiriou	182
17	Evaluation of the histological size of the sentinel lymph node metastases using RT–PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer 2009 ·Breast Cancer Research and Treatment ·Isabelle Veys, Samira Majjaj, Rodrigo Salgado, (unknown), (unknown), (unknown), Pierre Bourgeois, Jean‐Marie Nogaret, Denis Larsimont, Virginie Durbecq	10
18	Eighteen months clinical experience with the GeneSearch breast lymph node assay 2009 ·The American Journal of Surgery ·Isabelle Veys, Virginie Durbecq, Samira Majjaj, (unknown), (unknown), Nicolas Sirtaine, (unknown), Dina Hertens, Francesco Feoli, Pierre Bourgeois, Jean‐Marie Nogaret, Denis Larsimont	18
19	Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes 2008 ·European Journal of Surgical Oncology ·(unknown), Isabelle Veys, Samira Majjaj, Laurence Lespagnard, (unknown), Ghizlane Rouas, (unknown), (unknown), Dina Hertens, Francesco Feoli, Pierre Bourgeois, Virginie Durbecq, Denis Larsimont, Jean‐Marie Nogaret	33
20	Expression Cloning of an Interferon-inducible 17-kDa Membrane Protein Implicated in the Control of Cell Growth 1995 ·Journal of Biological Chemistry ·Gisèle A. Deblandre, Olivier Marinx, Sharon S. Evans, Samira Majjaj, Oberdan Léo, Daniel Caput, Georges Huez, Marc Wathelet	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact